Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system (Q38770352)

6 September 2017

Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system (English)

1 reference

6 September 2017

0 references

Douglas L Feinstein

1

1 reference

6 September 2017

Sergey Kalinin

series ordinal

2

1 reference

6 September 2017

David Braun

series ordinal

3

1 reference

6 September 2017

language of work or name

English

0 references

publication date

10 March 2016

1 reference

Journal of Neurochemistry

6 September 2017

25

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 September 2017

139 Suppl 2

1 reference

6 September 2017

154-178

1 reference

Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease

6 September 2017

1 reference

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

21 January 2018

1 reference

Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.

21 January 2018

1 reference

Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo

21 January 2018

1 reference

Brain structures and receptors involved in alertness

21 January 2018

1 reference

The relationship between subcortical tau pathology and Alzheimer's disease.

21 January 2018

1 reference

Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem.

21 January 2018

1 reference

Pathophysiological background and clinical characteristics of sleep disorders in multiple sclerosis

21 January 2018

1 reference

The locus ceruleus norepinephrine system: functional organization and potential clinical significance

21 January 2018

1 reference

The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

Is multiple sclerosis the equivalent of Parkinson's disease for noradrenaline?

21 January 2018

1 reference

Noradrenergic modulation of wakefulness/arousal

21 January 2018

1 reference

Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development

21 January 2018

1 reference

Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.

21 January 2018

1 reference

Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder.

21 January 2018

1 reference

Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

21 January 2018

1 reference

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

21 January 2018

1 reference

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

21 January 2018

1 reference

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

21 January 2018

1 reference

Postmortem locus coeruleus neuron count in three American veterans with probable or possible war-related PTSD.

21 January 2018

1 reference

Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.

21 January 2018

1 reference

The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease

21 January 2018

1 reference

Aggressive behavior during social interaction in mice is controlled by the modulation of tyrosine hydroxylase expression in the prefrontal cortex.

21 January 2018

1 reference

Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder

21 January 2018

1 reference

Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression

21 January 2018

1 reference

Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization.

21 January 2018

1 reference

α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction

21 January 2018

1 reference

Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity

21 January 2018

1 reference

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

21 January 2018

1 reference

Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome

21 January 2018

1 reference

Noradrenaline acting on astrocytic β₂-adrenoceptors induces neurite outgrowth in primary cortical neurons

21 January 2018

1 reference

Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production

21 January 2018

1 reference

Neuromelanic pigment in substantia nigra neurons of rats and dogs.

21 January 2018

1 reference

7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity

21 January 2018

1 reference

Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond

21 January 2018

1 reference

Neuronal vulnerability in Parkinson's disease.

21 January 2018

1 reference

Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque.

21 January 2018

1 reference

7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders.

21 January 2018

1 reference

Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions

21 January 2018

1 reference

Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients.

21 January 2018

1 reference

Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement

21 January 2018

1 reference

MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis

21 January 2018

1 reference

A Sympathomometic Pressor Substance in Animal Organ Extracts

21 January 2018

1 reference

Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures.

21 January 2018

1 reference

Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation.

21 January 2018

1 reference

Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis.

21 January 2018

1 reference

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release

21 January 2018

1 reference

Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response

21 January 2018

1 reference

Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy

21 January 2018

1 reference

Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses

21 January 2018

1 reference

Noradrenaline in Parkinson's disease: from disease progression to current therapeutics.

21 January 2018

1 reference

Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.

21 January 2018

1 reference

Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals

21 January 2018

1 reference

Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms

21 January 2018

1 reference

Effect of vinpocetine on noradrenergic neurons in rat locus coeruleus.

21 January 2018

1 reference

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

Intrinsic regulation of brain inflammatory responses.

21 January 2018

1 reference

Noradrenergic dysfunction in Alzheimer's disease.

21 January 2018

1 reference

A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells

21 January 2018

1 reference

Norepinephrine increases I kappa B alpha expression in astrocytes

21 January 2018

1 reference

Altered locus coeruleus-norepinephrine function following single prolonged stress

21 January 2018

1 reference

Disease-specific patterns of locus coeruleus cell loss

21 January 2018

1 reference

The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage

21 January 2018

1 reference

The influence of beta-blockers on delayed memory function in people with cognitive impairment.

21 January 2018

1 reference

L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug

21 January 2018

1 reference

Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.

21 January 2018

1 reference

Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice.

21 January 2018

1 reference

Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action.

21 January 2018

1 reference

Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice

21 January 2018

1 reference

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide.

21 January 2018

1 reference

Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview.

21 January 2018

1 reference

Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion

21 January 2018

1 reference

Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression.

21 January 2018

1 reference

Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.

21 January 2018

1 reference

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

21 January 2018

1 reference

Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of α2 adrenergic receptors.

21 January 2018

1 reference

Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators

21 January 2018

1 reference

Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons

21 January 2018

1 reference

Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons

21 January 2018

1 reference

Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss

21 January 2018

1 reference

Age-dependent changes in noradrenergic innervations of the frontal cortex in F344 rats

21 January 2018

1 reference

Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: Suppression of NFκB nuclear translocation and subsequent STAT1 phosphorylation.

21 January 2018

1 reference

Selective ablation of dopamine β-hydroxylase neurons in the brain by immunotoxin-mediated neuronal targeting: new insights into brain catecholaminergic circuitry and catecholamine-related diseases

21 January 2018

1 reference

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.

21 January 2018

1 reference

Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits

21 January 2018

1 reference

Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice

21 January 2018

1 reference

Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism

21 January 2018

1 reference

Norepinephrine provides short-term neuroprotection against Aβ1-42 by reducing oxidative stress independent of Nrf2 activation

21 January 2018

1 reference

Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist.

21 January 2018

1 reference

Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.

21 January 2018

1 reference

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin.

21 January 2018

1 reference

Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension

21 January 2018

1 reference

Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.

21 January 2018

1 reference

Ear2 deletion causes early memory and learning deficits in APP/PS1 mice

21 January 2018

1 reference

Long-term effects of RU24722 on tyrosine hydroxylase of the rat brain

21 January 2018

1 reference

Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Noradrenergic changes and memory loss in aged mice.

21 January 2018

1 reference

Norepinephrine induces the expression of interleukin-6 via β-adrenoreceptor-NAD(P)H oxidase system -NF-κB dependent signal pathway in U937 macrophages

21 January 2018

1 reference

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

21 January 2018

1 reference

Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems

21 January 2018

1 reference

Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro

21 January 2018

1 reference

Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets

21 January 2018

1 reference

Brainstem neuropathology in a mouse model of Niemann-Pick disease type C.

21 January 2018

1 reference

Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice.

21 January 2018

1 reference

Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models

21 January 2018

1 reference

Norepinephrine protects cortical neurons against microglial-induced cell death.

21 January 2018

1 reference

Effects of noradrenaline on neuronal NOS2 expression and viability.

21 January 2018

1 reference

Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta.

21 January 2018

1 reference

Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline.

21 January 2018

1 reference

Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis.

21 January 2018

1 reference

The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system

21 January 2018

1 reference

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

21 January 2018

1 reference

The noradrenergic system in Alzheimer and multi-infarct dementias

21 January 2018

1 reference

Plasticity of tyrosine hydroxylase gene expression within BALB/C and C57Black/6 mouse locus coeruleus

21 January 2018

1 reference

Noradrenergic mechanisms in neurodegenerative diseases: a theory

21 January 2018

1 reference

Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis

21 January 2018

1 reference

Neuroprotective effects of the alpha2-adrenoceptor antagonists, (+)-efaroxan and (+/-)-idazoxan, against quinolinic acid-induced lesions of the rat striatum

21 January 2018

1 reference

BDNF is necessary for maintenance of noradrenergic innervations in the aged rat brain

21 January 2018

1 reference

Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex

21 January 2018

1 reference

Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.

21 January 2018

1 reference

Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity

21 January 2018

1 reference

Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions.

21 January 2018

1 reference

Autism, fever, epigenetics and the locus coeruleus

21 January 2018

1 reference

Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study

21 January 2018

1 reference

Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.

21 January 2018

1 reference

Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals

21 January 2018

1 reference

Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases

21 January 2018

1 reference

Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference

21 January 2018

1 reference

The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease

21 January 2018

1 reference

Cataplexy and sleep disorders in Niemann-Pick type C disease

21 January 2018

1 reference

The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF.

21 January 2018

1 reference

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population

21 January 2018

1 reference

Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging.

21 January 2018

1 reference

Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse

21 January 2018

1 reference

Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice

21 January 2018

1 reference

Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration

21 January 2018

1 reference

Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge.

21 January 2018

1 reference

Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes.

21 January 2018

1 reference

Uptake of environmental toxicants by the locus ceruleus: a potential trigger for neurodegenerative, demyelinating and psychiatric disorders

21 January 2018

1 reference

Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons

21 January 2018

1 reference

Selegiline reverses aβ₂₅₋₃₅-induced cognitive deficit in male mice.

21 January 2018

1 reference

Treatment of mood disorders in multiple sclerosis.

21 January 2018

1 reference

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

21 January 2018

1 reference

Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy

21 January 2018

1 reference

Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus

21 January 2018

1 reference

Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.

21 January 2018

1 reference

The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

21 January 2018

1 reference

MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine.

21 January 2018

1 reference

Traumatic brain injury stimulates hippocampal catechol-O-methyl transferase expression in microglia

21 January 2018

1 reference

The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.

21 January 2018

1 reference

Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.

21 January 2018

1 reference

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans

21 January 2018

1 reference

Lifelong ethanol consumption and loss of locus coeruleus neurons in AA and ANA rats.

21 January 2018

1 reference

Norepinephrine: The redheaded stepchild of Parkinson's disease

21 January 2018

1 reference

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice

21 January 2018

1 reference

Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart

21 January 2018

1 reference

DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action

21 January 2018

1 reference

Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease

21 January 2018

1 reference

Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

21 January 2018

1 reference

Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome.

21 January 2018

1 reference

Monoamine Oxidase and Acetylcholinesterase Activity in Animals with Experimental Allergic Encephalomyelitis

21 January 2018

1 reference

Adrenergic regulation of innate immunity: a review

21 January 2018

1 reference

Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.

21 January 2018

1 reference

Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors.

21 January 2018

1 reference

Organization of the locus coeruleus-norepinephrine system

21 January 2018

1 reference

Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.

21 January 2018

1 reference

Catechol-o-methyltransferase and Alzheimer's disease: a review of biological and genetic findings

21 January 2018

1 reference

Time-dependent activation of Phox2a by the cyclic AMP pathway modulates onset and duration of p27Kip1 transcription

21 January 2018

1 reference

Tyrosine hydroxylase mRNA is increased in old age and norepinephrine uptake transporter mRNA is decreased in middle age in locus coeruleus of Brown-Norway rats.

21 January 2018

1 reference

Increasing CNS noradrenaline reduces EAE severity

21 January 2018

1 reference

Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice

21 January 2018

1 reference

Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.

21 January 2018

1 reference

Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease

21 January 2018

1 reference

Catecholamine-Based Treatment in AD Patients: Expectations and Delusions.

21 January 2018

1 reference

A quantitative histological study of neuronal loss from the locus coeruleus of ageing mice.

21 January 2018

1 reference

Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

Functional neuroanatomy of the central noradrenergic system

21 January 2018

1 reference

Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia

21 January 2018

1 reference

Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system

21 January 2018

1 reference

Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice.

21 January 2018

1 reference

A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat

21 January 2018

1 reference

Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis.

21 January 2018

1 reference

Effect of a new eburnamine derivative, RU 24722, on the turnover of monoamines in mouse brain: Selective and reversible decrease of noradrenaline

21 January 2018

1 reference

Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant.

21 January 2018

1 reference

Different rates of age-related loss for four murine monoaminergic neuronal populations.

21 January 2018

1 reference

Congenital dopamine-beta-hydroxylase deficiency in humans

21 January 2018

1 reference

Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

21 January 2018

1 reference

Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons.

21 January 2018

1 reference

The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress.

21 January 2018

1 reference

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care

21 January 2018

1 reference

Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress.

21 January 2018

1 reference

Félix Vicq d'Azyr (1746-1794): early founder of neuroanatomy and royal French physician.

21 January 2018

1 reference

Projection specificity in heterogeneous locus coeruleus cell populations: implications for learning and memory

21 January 2018

1 reference

Neuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responses

21 January 2018

1 reference

Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models

21 January 2018

1 reference

Eburnamine derivatives and the brain

21 January 2018

1 reference

Activation of noradrenergic transmission by alpha2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb

21 January 2018

1 reference

A Quantitative Study of the Pigmented Neurons in the Nuclei Locus Coeruleus and Subcoeruleus in Man as Related to Aging

21 January 2018

1 reference

Norepinephrine activates NF-κB transcription factor in cultured rat pineal gland

21 January 2018

1 reference

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

21 January 2018

1 reference

The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines

21 January 2018

1 reference

Vagus nerve stimulation…25 years later! What do we know about the effects on cognition?

21 January 2018

1 reference

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

21 January 2018

1 reference

Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer's disease patients

21 January 2018

1 reference

Functional consequences of locus coeruleus degeneration in Alzheimer's disease

21 January 2018

1 reference

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

21 January 2018

1 reference

The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's disease

21 January 2018

1 reference

Biomathematical analysis of the neuronal loss in the aging human brain of both sexes, demonstrated in pigment preparations of the pars cerebellaris loci coerulei.

21 January 2018

1 reference

Locus coeruleus neurons: cessation of activity during cataplexy.

21 January 2018

1 reference

Sleep drives metabolite clearance from the adult brain

21 January 2018

1 reference

Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view

21 January 2018

1 reference

Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-β peptide via action at β-adrenoceptors and activation of cAMP/PKA pathway in human THP-1 macrophages

21 January 2018

1 reference

Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson׳s disease.

21 January 2018

1 reference

Noradrenaline in Alzheimer-type dementia and Down syndrome

21 January 2018

1 reference

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

21 January 2018

1 reference

Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer's disease.

21 January 2018

1 reference

7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.

21 January 2018

1 reference

No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.

21 January 2018

1 reference

Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine beta-hydroxylase in the locus coeruleus and adrenal glands of rats

21 January 2018

1 reference

Degeneration in Arousal Neurons in Chronic Sleep Disruption Modeling Sleep Apnea

21 January 2018

1 reference

Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome

21 January 2018

1 reference

beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1

21 January 2018

1 reference

Locus coeruleus involvement in Huntington's disease

21 January 2018

1 reference

Ontogeny of tyrosine hydroxylase concentration in locus coeruleus of newborn rats: long-term effects of RU24722.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JNC.13447

1 reference

6 September 2017

1 reference